FDA Approves Cimzia to Treat Crohn's Disease A new drug
FDA Approves Cimzia to Treat Crohn's Disease
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies.